Concomitant occurrence of itraconazole-resistant and -susceptible strains of Aspergillus fumigatus in routine cultures - PubMed (original) (raw)
doi: 10.1093/jac/dku410. Epub 2014 Oct 17.
Affiliations
- PMID: 25326091
- DOI: 10.1093/jac/dku410
Concomitant occurrence of itraconazole-resistant and -susceptible strains of Aspergillus fumigatus in routine cultures
Suhail Ahmad et al. J Antimicrob Chemother. 2015 Feb.
Abstract
Objectives: Resistance to triazoles in Aspergillus fumigatus has emerged in several countries and is usually mediated by mutations in the cyp51A gene. We determined the presence of both itraconazole-susceptible and -resistant A. fumigatus in routine cultures isolated from environmental and clinical samples.
Methods: A total of 50 environmental and 16 clinical A. fumigatus isolates obtained from single colonies were tested for itraconazole susceptibility by Etest. Serial dilution and plating for selected A. fumigatus cultures were performed to separate triazole-susceptible and -resistant phenotypes. Antifungal drug susceptibility of subcultures to itraconazole, posaconazole and voriconazole was determined by the broth microdilution method. Itraconazole resistance was determined by the presence of tandem repeats in the promoter region and other resistance-conferring mutations by PCR and/or direct DNA sequencing of cyp51A. Genotyping was performed with a panel of nine microsatellite loci.
Results: PCR amplification of the promoter region identified 1 of 50 environmental and 2 of 16 clinical A. fumigatus isolates as mixed (itraconazole-resistant and -susceptible) cultures, while the remaining isolates yielded patterns that were consistent with their data for susceptibility to itraconazole. Purified subcultures yielded distinct susceptibility profiles, concomitant with genetic determinants of triazole susceptibility/resistance in cyp51A and different microsatellite patterns.
Conclusions: Concomitant presence of triazole-susceptible and -resistant strains in single colonies of routine A. fumigatus cultures, obtained from environmental and clinical samples, has been conclusively demonstrated.
Keywords: A. fumigatus; cyp51A mutations; invasive aspergillosis; resistance.
© The Author 2014. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.
Similar articles
- Occurrence of triazole-resistant Aspergillus fumigatus with TR34/L98H mutations in outdoor and hospital environment in Kuwait.
Ahmad S, Khan Z, Hagen F, Meis JF. Ahmad S, et al. Environ Res. 2014 Aug;133:20-6. doi: 10.1016/j.envres.2014.05.009. Epub 2014 Jun 4. Environ Res. 2014. PMID: 24906064 - Isolation of multiple-triazole-resistant Aspergillus fumigatus strains carrying the TR/L98H mutations in the cyp51A gene in India.
Chowdhary A, Kathuria S, Randhawa HS, Gaur SN, Klaassen CH, Meis JF. Chowdhary A, et al. J Antimicrob Chemother. 2012 Feb;67(2):362-6. doi: 10.1093/jac/dkr443. Epub 2011 Oct 25. J Antimicrob Chemother. 2012. PMID: 22028200 - First determination of azole resistance in Aspergillus fumigatus strains carrying the TR34/L98H mutations in Turkey.
Özmerdiven GE, Ak S, Ener B, Ağca H, Cilo BD, Tunca B, Akalın H. Özmerdiven GE, et al. J Infect Chemother. 2015 Aug;21(8):581-6. doi: 10.1016/j.jiac.2015.04.012. Epub 2015 May 14. J Infect Chemother. 2015. PMID: 26048062 - Exploring azole antifungal drug resistance in Aspergillus fumigatus with special reference to resistance mechanisms.
Chowdhary A, Sharma C, Hagen F, Meis JF. Chowdhary A, et al. Future Microbiol. 2014;9(5):697-711. doi: 10.2217/fmb.14.27. Future Microbiol. 2014. PMID: 24957095 Review. - [The Current Status of Drug-resistant Aspergillus].
Tashiro M, Izumikawa K. Tashiro M, et al. Med Mycol J. 2016;57(3):J103-12. doi: 10.3314/mmj.16.001. Med Mycol J. 2016. PMID: 27581778 Review. Japanese.
Cited by
- Azole-Resistant COVID-19-Associated Pulmonary Aspergillosis in an Immunocompetent Host: A Case Report.
Meijer EFJ, Dofferhoff ASM, Hoiting O, Buil JB, Meis JF. Meijer EFJ, et al. J Fungi (Basel). 2020 Jun 6;6(2):79. doi: 10.3390/jof6020079. J Fungi (Basel). 2020. PMID: 32517166 Free PMC article. - Proteomic Analysis of Pathogenic Fungi Reveals Highly Expressed Conserved Cell Wall Proteins.
Champer J, Ito JI, Clemons KV, Stevens DA, Kalkum M. Champer J, et al. J Fungi (Basel). 2016 Mar;2(1):6. doi: 10.3390/jof2010006. Epub 2016 Jan 12. J Fungi (Basel). 2016. PMID: 26878023 Free PMC article. - Triazole-Resistant Aspergillus fumigatus from Fungicide-Experienced Soils in Naivasha Subcounty and Nairobi County, Kenya.
Kemoi EK, Nyerere A, Bii CC. Kemoi EK, et al. Int J Microbiol. 2018 Jun 26;2018:7147938. doi: 10.1155/2018/7147938. eCollection 2018. Int J Microbiol. 2018. PMID: 30046310 Free PMC article. - Elevated MIC Values of Imidazole Drugs against Aspergillus fumigatus Isolates with TR34/L98H/S297T/F495I Mutation.
Chen Y, Li Z, Han X, Tian S, Zhao J, Chen F, Su X, Zhao J, Zou Z, Gong Y, Qu F, Qiu G, Wang S, Jia X, Lu Z, Hu M, Huang L, Verweij PE, Han L. Chen Y, et al. Antimicrob Agents Chemother. 2018 Apr 26;62(5):e01549-17. doi: 10.1128/AAC.01549-17. Print 2018 May. Antimicrob Agents Chemother. 2018. PMID: 29507067 Free PMC article. - Insights into Aspergillus fumigatus Colonization in Cystic Fibrosis and Cross-Transmission between Patients and Hospital Environments.
Pontes L, Perini Leme Giordano AL, Reichert-Lima F, Gualtieri Beraquet CA, Leite Pigolli G, Arai T, Ribeiro JD, Gonçalves AC, Watanabe A, Goldman GH, Moretti ML, Zaninelli Schreiber A. Pontes L, et al. J Fungi (Basel). 2024 Jun 29;10(7):461. doi: 10.3390/jof10070461. J Fungi (Basel). 2024. PMID: 39057346 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources